The Non-Malignant Channel is supported with funding from Agios (Gold).
The Sickle Cell Disease Channel is supported with funding from Agios (Gold).
The Thalassemia Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2025 | First miniaturized electrophoresis diagnostic platform in the USA for hemoglobinopathies
Akshat Jain, MD, MPH, FRCP, Loma Linda University, San Bernardino, CA, discusses the development of the first miniaturized electrophoresis diagnostic platform in the USA for hemoglobinopathies, which enables rapid and accurate diagnosis and therapeutic monitoring of sickle cell disease (SCD) and thalassemia in real-time. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
